Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

CHU Gabriel-Montpied
Sponsor

CHU Gabriel-Montpied

France 58 Rue Montalembert, 63000 Clermont Ferrand, France

About the sponsor

Allogeneic haematopoietic stem cell transplantation for haematological malignancies is a key area of interest, with attention to post-transplant complications and immune recovery.

  • Graft-versus-host disease
  • Relapse-free survival
  • Fecal microbiota transplantation

Research activity in this domain focuses on improving outcomes after intensive haematologic treatment and transplantation.

About Specializations

CHU Gabriel-Montpied runs clinical trials in conditions such as Haematological malignancy, Allogenic stem cell transplantation, Chronic kidney disease, Premature rupture of membranes, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

4 clinical trials

Haematological malignancy+1

Recruiting

Study on Fecal Microbiota Transplantation to Prevent Complications in Patients After Stem Cell Transplant for Blood Cancer

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Allogeneic Faecal Microbiota
  • Sponsor:CHU Gabriel-Montpied

Chronic kidney disease

Recruiting

Study on Ketoanalogue Supplementation for Muscle Protection in Patients with Stage 4 and 5 Chronic Kidney Disease on a Low Protein Diet

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Keto-Leucine Calcium
  • Sponsor:CHU Gabriel-Montpied

Premature rupture of membranes

Not recruiting

Study Comparing Balloon with Oxytocin and Oral Misoprostol for Inducing Labor in First-Time Mothers with Premature Rupture of Membranes at Term

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Amoxicillin
  • Sponsor:CHU Gabriel-Montpied

Acute respiratory distress syndrome

Not recruiting

A Study of Inhaled Sevoflurane Compared to Standard Intravenous Sedation (Dexmedetomidine, Midazolam, or Propofol) in ICU Patients at Risk of Acute Respiratory Distress Syndrome

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Dexmedetomidine
  • Sponsor:CHU Gabriel-Montpied

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.